Related Experiment Videos
Neutrophil activation in Behçet's disease
E Eksioglu-Demiralp1, H Direskeneli, A Kibaroglu
1Department of Hematology-Immunology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Clinical and Experimental Rheumatology
|January 5, 2002
Summary
Neutrophil function in Behçet's disease (BD) was studied. Findings suggest neutrophils are pre-activated in vivo in BD patients, similar to other severe inflammatory conditions.
Area of Science:
- Immunology
- Pathophysiology
Background:
- Neutrophils play a key role in the inflammatory processes of Behçet's disease (BD).
- Understanding neutrophil behavior is crucial for elucidating BD pathogenesis.
Purpose of the Study:
- To investigate neutrophil functions, including oxidative burst and phagocytosis, in BD patients.
- To analyze surface molecule expression (CD10, CD14, CD16) related to neutrophil activation in BD.
Main Methods:
- Flow cytometry was employed to assess neutrophil oxidative burst and phagocytic capacity.
- Expression levels of CD10, CD14, and CD16 on neutrophils were measured in BD patients, inflammatory arthropathy patients, sepsis patients, and healthy controls.
Main Results:
- Neutrophil oxidative burst was significantly reduced in BD and sepsis patients compared to controls.
- Phagocytosis of E. coli was normal in BD patients but reduced in diseased controls.
- Increased CD10 and CD14 expression was observed in BD and diseased controls.
- CD16 expression was lower in BD patients and sepsis patients.
Conclusions:
- The study indicates that neutrophils are pre-activated in vivo in Behçet's disease patients.
- This neutrophil activation pattern is also characteristic of other severe inflammatory disorders.